QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)
QQQ   387.29 (+0.25%)
AAPL   193.42 (+2.11%)
MSFT   372.52 (+0.92%)
META   318.29 (-0.54%)
GOOGL   130.99 (+1.33%)
AMZN   146.88 (+1.41%)
TSLA   238.72 (+1.33%)
NVDA   465.66 (+2.33%)
NIO   7.43 (+1.37%)
BABA   72.39 (-0.88%)
AMD   118.38 (-0.16%)
T   17.22 (+3.36%)
F   10.60 (-0.93%)
MU   73.69 (-0.81%)
CGC   0.67 (-11.90%)
GE   120.24 (-1.06%)
DIS   90.80 (-1.32%)
AMC   7.03 (-6.15%)
PFE   29.09 (-0.65%)
PYPL   57.92 (-3.22%)
XOM   100.44 (-1.94%)

CSL Stock Price, News & Analysis (ASX:CSL)

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
869,289 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.37%
Price Target
N/A

CSL stock logo

About CSL Stock (ASX:CSL)

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.


CSL Stock News Headlines

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Could CSL stock be a millionaire-maker at $261
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Melbourne earns top marks for research
What's the outlook for CSL shares in 2024?
Why has Goldman Sachs just upgraded CSL shares?
See More Headlines
Receive CSL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2019
Ex-Dividend for 10/3 Dividend
9/10/2023
Dividend Payable
10/03/2023
Today
12/05/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
32,065
Year Founded
N/A

Profitability

Net Income
$2.19 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.31 billion
Book Value
A$32.73 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.27
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Paul F. McKenzie Ph.D. (Age 57)
    MD, CEO & Executive Director
    Comp: $4.19M
  • Ms. Joy Carolyn Linton B.Com. (Age 58)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $3.12M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 62)
    BS(Hons), J.D., Executive VP of Legal & General Counsel
    Comp: $1.67M
  • Christina Hickie
    Senior Manager of Communications
  • Dr. Karen Etchberger (Age 65)
    Executive Vice President of Quality & Business Services
    Comp: $1.57M
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific
  • Mr. William Campbell B.S. (Age 63)
    Executive VP & Chief Commercial Officer
    Comp: $1.85M
  • Dr. Andrew D. Nash (Age 61)
    Senior Vice President of Research
  • Dr. William Mezzanotte M.D. (Age 64)
    M.P.H., Executive VP & Head of Research and Development
    Comp: $2.22M














CSL Stock Analysis - Frequently Asked Questions

How were CSL's earnings last quarter?

CSL Limited (ASX:CSL) issued its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 13.85% and a net margin of 16.48%.

How often does CSL pay dividends? What is the dividend yield for CSL?

CSL declared a Final dividend on Thursday, September 7th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 1.992 per share on Tuesday, October 3rd. This represents a dividend yield of 0.74%. The ex-dividend date is Sunday, September 10th. This is a positive change from the stock's previous Final dividend of A$1.61.
Read our dividend analysis for CSL
.

Is CSL a good dividend stock?

CSL (ASX:CSL) pays an annual dividend of A$3.63 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 53.70%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for CSL.

What other stocks do shareholders of CSL own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra Group (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B).

This page (ASX:CSL) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -